Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Provectus Biopharmaceuticals Inc (NYSE MKT LLC:PVCT)

0.0992
Delayed Data
As of 3:59pm ET
 +0.0021 / +2.16%
Today’s Change
0.09
Today|||52-Week Range
0.60
-74.56%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization677.3K677.5K679.7K684.3K
 
 
 
 
 
 
Operating ExpensesGross Income-677.3K-677.5K-679.7K-684.3K
 
 
 
 
 
General Expenses13.7M12.4M16.1M24.0M
 
 
 
 
 
Research And Development5.0M3.6M5.1M10.7M
 
 
 
 
 
Total Operating Expenses14.3M13.0M16.8M24.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.3M-13.0M-16.8M-24.7M
 
 
 
 
 
Extraordinary Credit1.8M0.006.6M146.6K
 
 
 
 
Extraordinary Charge0.00-14.7M0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.6M-27.7M-10.2M-24.5M
 
 
 
 
 
Preferred Dividend-183.2K-1.2M0.000.00
 
 
 
Net Income-12.6M-27.7M-10.2M-24.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS113.0M132.0M175.8M195.7M
 
 
 
 
 
Shares To Calculate EPS Diluted113.0M132.0M175.8M195.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.11-$0.22-$0.06-$0.13
 
 
 
 
 
EPS Diluted-$0.11-$0.22-$0.06-$0.13